Administration of Human Normal Immunoglobulin and Intravenous Immunoglobulin after measles exposure

Information about Human Normal Immunoglobulin [HNIG] and Intravenous Immunoglobulin [IVIG] medicines after exposure to measles

  • LN: 005964
  • Edition number: 1st Edition, version 1
  • Developed by: Dr Jessica Martin, Consultant in Infection Prevention and Control; Dr Christopher Hammond, Medical Director for Operations; Sean O’Riordan, Consultant in Paediatric Infectious Dieseases
    • Page last reviewed:
    • Next review date: